Minerva Neurosciences, Inc. financial data

Symbol
NERV on Nasdaq
Location
Burlington, MA
Fiscal year end
31 December
Latest financial report
11 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1373% % 68%
Debt-to-equity -178% % 25%
Return On Equity 496% %
Return On Assets -620% % -19144%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43,274,398 shares 519%
Common Stock, Shares, Outstanding 43,274,398 shares 519%
Entity Public Float $7,000,000 USD -46%
Common Stock, Value, Issued $4,327 USD 519%
Weighted Average Number of Shares Outstanding, Basic 8,463,581 shares 12%
Weighted Average Number of Shares Outstanding, Diluted 8,463,581 shares 12%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $5,759,473 USD -52%
General and Administrative Expense $9,343,497 USD -6.1%
Operating Income (Loss) $15,102,970 USD 31%
Net Income (Loss) Attributable to Parent $293,423,177 USD -20493%
Earnings Per Share, Basic -34.67 USD/shares -18347%
Earnings Per Share, Diluted -34.67 USD/shares -18347%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $82,301,813 USD 285%
Assets, Current $83,099,489 USD 273%
Property, Plant and Equipment, Net $0 USD -100%
Goodwill $14,869,399 USD 0%
Assets $97,968,888 USD 164%
Accounts Payable, Current $639,707 USD -60%
Liabilities, Current $2,290,473 USD -19%
Liabilities $233,755,048 USD 272%
Retained Earnings (Accumulated Deficit) $688,799,740 USD -74%
Stockholders' Equity Attributable to Parent $140,748,082 USD -448%
Liabilities and Equity $97,968,888 USD 164%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,071,960 USD 33%
Net Cash Provided by (Used in) Financing Activities $0 USD
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 250,000,000 shares 100%
Common Stock, Shares, Issued 43,274,398 shares 519%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,071,960 USD 33%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $82,401,813 USD 284%
Deferred Tax Assets, Valuation Allowance $99,670,683 USD 3.8%
Deferred Tax Assets, Gross $99,670,683 USD 3.8%
Deferred Tax Assets, Operating Loss Carryforwards $51,552,252 USD 20%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $1,327,372 USD 0.14%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%